Moderna (MRNA) Stock: Buy, Sell, or Hold?
MRNA - Moderna, Inc. Common Stock
$225.00
28.00 (14.21%)
▲
5d:
+18.41%
30d:
+64.69%
90d:
+235.77%
WAIT
LOW Confidence
Analysis Updated: Oct 9, 2026 12:00 AM ET
Earnings: Nov 05, 2026
24d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Sep 28, 2026 at $197.18 · last confirmed Oct 9, 2026
Strength: 8.0/10
Get Alerted When MRNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: MRNA is 14.3% above its trading range ($196.77). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: MRNA is 14.3% above its trading range ($196.77). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: MRNA is currently trading at $225.00, which is considered extended relative to its 30-day fair value range of $145.11 to $196.77.
Technical Outlook: Technically, MRNA is in a strong uptrend. The price is approaching resistance at $225.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 14.2% recently.
Market Sentiment: MRNA scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $121.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MRNA is in a strong uptrend. The price is approaching resistance at $225.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 14.2% recently.
Market Sentiment: MRNA scores 21/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $121.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$145.11 -
$196.77
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
10.5%
Protect Your Profits
MRNA is technically overbought (RSI 72). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+14.3% above its trading range)
- BEARISH: Weak technical setup (21/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+14.2%)
- BEARISH: Trading 46.2% above Wall St target ($121.00)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$145.11 -
$196.77
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$182.50
Resistance Level
$225.00
Current Trend
Strong Uptrend
Technical data as of
Oct 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-46.97
Wall Street Target
$121.00
(-46.2%)
Revenue Growth (YoY)
2.1%
Earnings Growth (YoY)
-85.1%
Profit Margin
-141.4%
Share & Embed Analysis
Last updated: October 11, 2026 1:35 PM ET
Data refreshes hourly during market hours. Next update: 2:35 PM
Data refreshes hourly during market hours. Next update: 2:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 62 BUY |
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
27 analysts |
$92 | 56 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 66 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1180 | 41 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 63 BUY |
Advanced MRNA Option Strategies
Professional options setups generated by AI based on today's MRNA price and gamma walls.
